Search the Newsreel

Guggenheim raises Humana stock price target on margin outlook

Guggenheim has increased its price target for Humana Inc. (NYSE:HUM) to $471 from $269, maintaining a Buy rating, based on the health insurer's focus on Medicare Advantage margin expansion. Despite a recent stock dip after Q2 2026 results, Guggenheim projects significant annual margin recovery …

This Humana Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday

This article details the top five stock downgrades by Wall Street analysts on Thursday. Notably, a Raymond James analyst downgraded Humana (NYSE: HUM) from Outperform to Market Perform. Other companies experiencing downgrades include Paymentus Holdings Inc (NYSE: PAY), Masco Corp (NYSE: MAS), Fiverr International …

Humana plans to exit some MA markets next year, affecting 600,000 members

Humana announced plans to exit some of its less profitable Medicare Advantage markets in 2027, which is expected to affect approximately 600,000 members. The company's primary goal is to achieve a sustainable margin of at least 3%. Despite these exits, Humana reported significant individual …

Humana Medicare Advantage Cuts: What are the recent changes made in your plan that you must know?

Humana is adjusting its Medicare Advantage plans for 2027, discontinuing some in certain markets due to rising medical costs and changes in federal reimbursement. While not all enrollees will be affected, members are advised to review their Annual Notice of Change (ANOC) and consider …

Ihuman Inc (IH) Financial Health: Profitability & Balance Sheet Analysis

Ihuman Inc (IH) has a robust financial status despite its low operating efficiency, with a current financial score of 6.75, ranking 300 out of 485 in the Software & IT Services industry. The company's latest quarterly revenue decreased by 8.51% year-over-year to $26.86M, and …

Humana Q2 Earnings Call Highlights

Humana's Q2 earnings call highlighted that the company is on track for its 2026 performance goals, emphasizing planned Medicare Advantage margin expansion by 2027 and aiming for a 3% pretax margin by 2028. The company is strategically exiting certain plans and focusing on efficiency …

Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Halper Sadeh LLC is investigating whether certain officers and directors of Humana Inc. breached their fiduciary duties to shareholders. The firm is encouraging long-term Humana shareholders to contact them to discuss their legal rights and options, which could include corporate governance reforms or financial …

Ensign Group, Humana, Vitas Healthcare, Option Care Health report second-quarter earnings

The Ensign Group, Humana, Vitas Healthcare, and Option Care Health recently reported their second-quarter earnings. Ensign Group saw strong demand and anticipates a busy acquisition period, planning to expand into new states and having acquired 71 assets since 2025. Humana reaffirmed its commitment to …

Humana Inc. Q2 2026 Earnings Call Summary

Humana Inc. Q2 2026 Earnings Call Summary - Moby Strategic Execution and Performance Drivers Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here. …

Humana Q2 Earnings Review: Management Tight-Lipped, But Recovery Still On Track (NYSE:HUM)

Humana Inc. reported Q2 2026 earnings, reiterating its goal of achieving a sustainable 3% pre-tax margin by 2028 through improved Medicare Advantage plan quality and operational efficiency. Despite strong revenue growth, profit margins have seen a significant decline, with Q2 2026 pre-tax margin at …

Humana Inc (HUM) Q2 2026 Earnings Call Highlights: Strategic Exits and Margin Expansion Plans

This article first appeared on GuruFocus. Operating Cost Ratio: Down 120 basis points year over year in Q2. Full-Year Operating Cost Reduction Expectation: Approximately 150 basis points. 2026 Cost Trend: High single-digit range, 7% to 8%, inclusive of medical and pharmacy. Individual MA Pretax …

Humana Inc Q2 2026: Revenue $40.9B, EPS $5.73— 10-Q Summary

Humana Inc. reported strong second-quarter 2026 results, with revenue reaching $40.9 billion and diluted EPS of $5.73. This represents double-digit year-over-year growth in both revenue (26.2%) and net income (27.6%), driven primarily by expansion in Medicare membership and higher per-member premiums. The company also …

[10-Q] HUMANA INC Quarterly Earnings Report

Humana Inc. (HUM) filed its unaudited quarterly report Form 10-Q for the period ended June 30, 2026. The report details $1.32 billion of commercial paper outstanding, $5.0 billion in revolving borrowing capacity, and the completed acquisition of MaxHealth for approximately $908 million. The company …

Why Humana Stock Is Falling After Earnings Beat Expectations

Humana reports a higher medical cost ratio and reaffirms, rather than raises, its full-year earnings guidance. Continue Reading

S&P 500 Stocks: GEHC Revives, Humana Fades On Earnings

GE HealthCare Technologies ran at the top of the S&P 500 Wednesday morning, while Humana was among major laggards after both companies posted better-than-expected Q2 earnings signaling a return to profit growth. GEHC broke above its recent trading range that followed its dive on …

Compared to Estimates, Humana (HUM) Q2 Earnings: A Look at Key Metrics

Humana (HUM) reported $40.89 billion in revenue for the quarter ended June 2026, representing a year-over-year increase of 26.2%. EPS of $7.61 for the same period compares to $6.27 a year ago. The reported revenue compares to the Zacks Consensus Estimate of $40.65 billion, …

Humana (HUM) Stock Looks Fairly Valued Despite Its 70% Run

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Humana stock has delivered a powerful run over the past year, yet on the current checks it no longer looks obviously cheap or obviously expensive. …

Humana Still Expects Weak 2026, Despite Solid Progress Early in Year

Humana, a top-tier medical insurer specializing in Medicare Advantage plans, is expected to have a weak 2026 despite making solid progress early in the year. The company's focus on serving the elderly aligns with US demographic trends and the increasing penetration of Medicare Advantage …

Humana Shares Fall Despite Second-Quarter Earnings Beat and Reaffirmed Outlook

Financial report ©Adobe Stock Images Humana Inc. (NYSE:HUM) shares fell nearly 9% in pre-market trading on Wednesday despite the health insurer reporting second-quarter earnings and revenue that exceeded Wall Street expectations while reaffirming its full-year adjusted earnings guidance. The company posted adjusted earnings of …

Humana (NYSE:HUM) Exceeds Q2 CY2026 Expectations

Humana (NYSE:HUM) Exceeds Q2 CY2026 Expectations Health insurance company Humana (NYSE:HUM) announced better-than-expected revenue in Q2 CY2026, with sales up 26.2% year on year to $40.87 billion. Its non-GAAP profit of $7.61 per share was 8.8% above analysts' consensus estimates. Is now the time …

Humana (HUM) Q2 Earnings and Revenues Top Estimates

Humana (HUM) came out with quarterly earnings of $7.61 per share, beating the Zacks Consensus Estimate of $6.22 per share. This compares to earnings of $6.27 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings …

Humana cuts 2026 profit outlook on lower Medicare star ratings

Humana cut its full-year earnings outlook on Wednesday as lower Medicare Advantage Star Ratings reduced the quality bonuses it receives from the federal government. The health insurer revised its full-year GAAP earnings target to a minimum of $6.52 per share, compared with its earlier …

Humana Adds Anthropic and Former Aflac Executives to Board

Humana Inc. (NYSE: HUM) has announced the election of Paul Smith and Frederick Crawford to its Board of Directors, effective immediately. Smith, Chief Commercial Officer at Anthropic, PBC, brings over 30 years of experience in enterprise technology go-to-market strategies, while Crawford, former President and …

Humana falls despite beating second quarter estimates

Investing.com -- Humana Inc. (NYSE: HUM) reported second-quarter earnings before the open on Wednesday, topping consensus expectations. Adjusted earnings per share of $7.61 beat the analyst estimate of $7.23 by $0.38, though shares fell 8.7% premarket following the results. Revenue for the quarter reached …

Humana Q2 Profit Climbs, Cuts FY26 EPS Outlook, Backs Adj. Earnings, Revenue View; Stock Down

Humana, Inc. reported higher second-quarter profit with strong revenue growth but trimmed its fiscal 2026 reported earnings outlook. Despite the cut in the reported EPS view, the company maintained its adjusted earnings and revenue outlook for the fiscal year. Following the announcement, Humana's shares …

Humana Inc. $HUM Stock Position Increased by Redwood Grove Capital LLC

Redwood Grove Capital LLC increased its stake in Humana Inc. by 8.7% in the first quarter, making it their 4th largest holding. Other hedge funds also adjusted their positions in the health insurance provider. Humana recently reported strong quarterly earnings, beating analyst expectations, and …

Earnings Flash (HUM) Humana Inc. Reports Q2 Revenue $40.87B, vs. FactSet Est of $40.57B

Humana Inc. reported its second-quarter revenue reached $40.87 billion, surpassing FactSet's estimate of $40.57 billion. The company also announced that its Q2 adjusted earnings and revenue rose, and it affirmed its full-year 2026 adjusted EPS outlook of at least $9.00, exceeding FactSet's estimate of …

Humana beats quarterly profit estimates as medical costs stay in line

July 29 (Reuters) - Humana on Wednesday beat Wall Street estimates for second-quarter earnings as the ‌health insurer's spend on medical services was in ‌line with expectations, but it left its annual adjusted profit ​forecast unchanged. Shares of the company were down about 9% …

Humana Reports Second Quarter 2026 Financial Results; Affirms Full Year 2026 Adjusted Financial Guidance

Reports 2Q26 earnings per share (EPS) of $5.73 on a GAAP basis, Adjusted EPS of $7.61; reports year to date (YTD) 2026 EPS of $15.55 on a GAAP basis, $17.91 on an Adjusted basis 2Q26 Insurance segment GAAP benefit ratio of 91.2 percent, in …

Arrowstreet Capital Limited Partnership Raises Stock Holdings in Humana Inc. $HUM

Arrowstreet Capital Limited Partnership increased its stake in Humana Inc. by 26.7% in the first quarter, now owning 235,493 shares valued at $40.83 million. Other hedge funds also adjusted their positions, and institutional investors collectively own 92.38% of the company's stock. Analysts have given …

Humana (HUM) Could Be 83% Overvalued On Medicare Advantage Study And Earnings Focus

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Humana (HUM) is back in focus after new research from Humana Healthcare Research on Medicare Advantage selection coincided with rising attention on the company's upcoming …

Humana leaves annual adjusted profit outlook unchanged, shares drop

Humana stock drops despite Q2 beat (update) (HUM:NYSE)

Humana Inc (HUM) pullback tests a strong 12-week healthcare-plan rally

Weekly market data show a softer latest week, lighter turnover and mixed confirmation after a sharp medium-term advance.

Humana Earnings Face High Expectations as Medicare Advantage Recovers

Humana reports earnings Wednesday after its stock surged this year on improving confidence in Medicare Advantage insurers. Investors will be watching medical costs and the company’s outlook. Continue Reading

Humana: Q2 Earnings Snapshot

Humana Inc. reported strong second-quarter earnings, with net income of $694 million, or $5.73 per share, adjusted to $7.61 per share. These results surpassed Wall Street expectations, which had estimated $6.22 per share. The health insurer also exceeded revenue forecasts, posting $40.87 billion, and …